Sigma Healthcare Limited Stock Australian S.E.
Equities
SIGAN
AU0000313298
Pharmaceuticals
Sales 2025 * | 6.39B 4.24B | Sales 2026 * | 6.83B 4.53B | Capitalization | 1.82B 1.21B |
---|---|---|---|---|---|
Net income 2025 * | 485M 322M | Net income 2026 * | 573M 380M | EV / Sales 2025 * | 0.37 x |
Net Debt 2025 * | 522M 346M | Net Debt 2026 * | 544M 361M | EV / Sales 2026 * | 0.35 x |
P/E ratio 2025 * |
27.6
x | P/E ratio 2026 * |
23.2
x | Employees | 1,900 |
Yield 2025 * |
2.93% | Yield 2026 * |
3.45% | Free-Float | 92.62% |
Latest transcript on Sigma Healthcare Limited
Managers | Title | Age | Since |
---|---|---|---|
Vikesh Ramsunder
CEO | Chief Executive Officer | 53 | 22-01-31 |
Mark Conway
DFI | Director of Finance/CFO | - | Oct. 31 |
Martin Hawkins
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | 23-10-05 |
Kathryn Spargo
BRD | Director/Board Member | 72 | 15-12-08 |
Michael Sammells
CHM | Chairman | - | 20-01-31 |
1st Jan change | Capi. | |
---|---|---|
+27.67% | 76.01B | |
-0.19% | 24.11B | |
+6.36% | 8.65B | |
+8.61% | 8.53B | |
-24.75% | 7.62B | |
+0.89% | 4.13B | |
-8.73% | 3.91B | |
-3.76% | 3.64B | |
+13.21% | 3.49B |